CY2009010I2 - Μεθοδος για εμπλουτισμο r-επιμερους 16,17-ακεταλης παραγωγων των 21-ακυλοξυ πρεγνα-1,4-διεν-11.βητα., 16.αλφα., 17.αλφα.-τριολ-3,20-διονης - Google Patents

Μεθοδος για εμπλουτισμο r-επιμερους 16,17-ακεταλης παραγωγων των 21-ακυλοξυ πρεγνα-1,4-διεν-11.βητα., 16.αλφα., 17.αλφα.-τριολ-3,20-διονης

Info

Publication number
CY2009010I2
CY2009010I2 CY2009010C CY2009010C CY2009010I2 CY 2009010 I2 CY2009010 I2 CY 2009010I2 CY 2009010 C CY2009010 C CY 2009010C CY 2009010 C CY2009010 C CY 2009010C CY 2009010 I2 CY2009010 I2 CY 2009010I2
Authority
CY
Cyprus
Prior art keywords
alpha
pregna
epimer
dien
triol
Prior art date
Application number
CY2009010C
Other languages
English (en)
Other versions
CY2009010I1 (el
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7804358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2009010(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of CY2009010I1 publication Critical patent/CY2009010I1/el
Publication of CY2009010I2 publication Critical patent/CY2009010I2/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY2009010C 1996-09-03 2009-07-24 Μεθοδος για εμπλουτισμο r-επιμερους 16,17-ακεταλης παραγωγων των 21-ακυλοξυ πρεγνα-1,4-διεν-11.βητα., 16.αλφα., 17.αλφα.-τριολ-3,20-διονης CY2009010I2 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19635498A DE19635498A1 (de) 1996-09-03 1996-09-03 Verfahren zur Epimerenanreicherung
PCT/EP1997/004716 WO1998009982A1 (en) 1996-09-03 1997-08-29 Process for r-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11.beta.,16.alpha.,17.alpha.-triol-3,20-dione derivatives

Publications (2)

Publication Number Publication Date
CY2009010I1 CY2009010I1 (el) 2010-07-28
CY2009010I2 true CY2009010I2 (el) 2010-07-28

Family

ID=7804358

Family Applications (2)

Application Number Title Priority Date Filing Date
CY0400039A CY2454B1 (en) 1996-09-03 2004-05-18 Process for r-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11-beta-, 16.alpha.,17.alpha.-triol-3,20-dione derivatives.
CY2009010C CY2009010I2 (el) 1996-09-03 2009-07-24 Μεθοδος για εμπλουτισμο r-επιμερους 16,17-ακεταλης παραγωγων των 21-ακυλοξυ πρεγνα-1,4-διεν-11.βητα., 16.αλφα., 17.αλφα.-τριολ-3,20-διονης

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY0400039A CY2454B1 (en) 1996-09-03 2004-05-18 Process for r-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11-beta-, 16.alpha.,17.alpha.-triol-3,20-dione derivatives.

Country Status (18)

Country Link
US (1) US6787533B1 (el)
EP (1) EP0929566B1 (el)
JP (1) JP3807509B2 (el)
AT (1) ATE229539T1 (el)
AU (1) AU736840B2 (el)
CA (1) CA2264863C (el)
CL (1) CL2004001297A1 (el)
CY (2) CY2454B1 (el)
CZ (1) CZ298789B6 (el)
DE (2) DE19635498A1 (el)
DK (1) DK0929566T3 (el)
EE (1) EE03927B1 (el)
ES (1) ES2188984T3 (el)
HU (1) HU228766B1 (el)
IL (1) IL128535A (el)
PL (1) PL186063B1 (el)
PT (1) PT929566E (el)
WO (1) WO1998009982A1 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
DE10055820C1 (de) * 2000-11-10 2002-07-25 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung eines Glucocorticoids
DE60142920D1 (de) 2000-11-10 2010-10-07 Nycomed Gmbh Verfahren zur herstellung von 16,17-ä(cyclohexylmethylen)bis(oxy)ü -11,21-dihydroxy-pregna-1,4-dien-3,20-dion oder ihre 21-isobutyrat durch transketalisation
US20040235811A1 (en) 2002-10-08 2004-11-25 Sepracor Inc. Fatty acid modified forms of glucocorticoids
ES2312844T3 (es) 2002-12-12 2009-03-01 Nycomed Gmbh Medicamento de combinacion de r, r-formoterol y ciclesonida.
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
WO2005025578A1 (en) 2003-09-16 2005-03-24 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
CN100345864C (zh) * 2004-10-29 2007-10-31 天津药业研究院有限公司 一种治疗呼吸道疾病的甾体药物的制备方法及其中间体
WO2007056181A2 (en) * 2005-11-02 2007-05-18 Sicor, Inc. Process for the preparation of ciclesonide
EP1904514A2 (en) * 2006-02-08 2008-04-02 Sicor, Inc. Crystalline forms of ciclesonide
WO2008015696A2 (en) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Process for preparing ciclesonide
WO2008062450A2 (en) * 2006-09-18 2008-05-29 Cadila Healthcare Limited Crystalline polymorphs of ciclesonide
EP2064227A2 (en) * 2006-09-19 2009-06-03 Cipla Ltd. Processes for the preparation of ciclesonide and its crystal form
JP2011513469A (ja) * 2008-03-13 2011-04-28 ファルマビオス ソシエタ ペル アチオニ プレグナン誘導体の製造法
IT1397499B1 (it) * 2009-01-09 2013-01-16 Farmabios Spa Processo per la preparazione di ciclesonide
US20100120737A1 (en) * 2008-11-10 2010-05-13 Martin Feth Amorphous ciclesonide
US9109005B2 (en) 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
RS62040B1 (sr) 2016-06-02 2021-07-30 Abbvie Inc Agonist receptora glukokortikoida i njegovi imunokonjugati
EP3658192B1 (en) 2017-12-01 2021-04-28 AbbVie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
CN109293730A (zh) * 2018-10-23 2019-02-01 山东泰华生物科技股份有限公司 一种环索奈德的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996359A (en) * 1972-05-19 1976-12-07 Ab Bofors Novel stereoisomeric component A of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steroid 21-acylates, compositions thereof, and method of treating therewith
US3992534A (en) * 1972-05-19 1976-11-16 Ab Bofors Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods
SE378110B (el) * 1972-05-19 1975-08-18 Bofors Ab
US4036831A (en) * 1975-10-28 1977-07-19 Steroid Development Company Establishment Trimethyl siloxane steroid intermediates
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
SE8604059D0 (sv) * 1986-09-25 1986-09-25 Astra Pharma Prod A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
PL164294B1 (pl) * 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
US5482935A (en) 1993-01-05 1996-01-09 American Home Product Corporation Anti-atherosclerotic use of 17 alpha-dihydroequilin
CZ287877B6 (cs) * 1993-04-02 2001-03-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Prednisolonové deriváty a farmaceutické prostředky s jejich obsahem
WO1995024416A1 (de) 1994-03-09 1995-09-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue silylverbindungen und ihre verwendung

Also Published As

Publication number Publication date
PL331699A1 (en) 1999-08-02
AU736840B2 (en) 2001-08-02
ATE229539T1 (de) 2002-12-15
DE69717836T2 (de) 2003-09-18
US6787533B1 (en) 2004-09-07
EE03927B1 (et) 2002-12-16
DE19635498A1 (de) 1998-03-26
JP3807509B2 (ja) 2006-08-09
JP2000517330A (ja) 2000-12-26
CZ298789B6 (cs) 2008-01-30
EP0929566A1 (en) 1999-07-21
EP0929566B1 (en) 2002-12-11
ES2188984T3 (es) 2003-07-01
EE9900079A (et) 1999-10-15
CY2009010I1 (el) 2010-07-28
CZ72799A3 (cs) 1999-09-15
CY2454B1 (en) 2005-06-03
CA2264863C (en) 2007-07-31
PL186063B1 (pl) 2003-09-30
HUP9904127A2 (hu) 2000-04-28
WO1998009982A1 (en) 1998-03-12
PT929566E (pt) 2003-04-30
CL2004001297A1 (es) 2005-04-15
IL128535A0 (en) 2000-01-31
IL128535A (en) 2003-07-06
DK0929566T3 (da) 2003-04-07
AU4456797A (en) 1998-03-26
HUP9904127A3 (en) 2001-02-28
DE69717836D1 (de) 2003-01-23
CA2264863A1 (en) 1998-03-12
HU228766B1 (hu) 2013-05-28

Similar Documents

Publication Publication Date Title
CY2009010I1 (el) Μεθοδος για εμπλουτισμο r-επιμερους 16,17-ακεταλης παραγωγων των 21-ακυλοξυ πρεγνα-1,4-διεν-11.βητα., 16.αλφα., 17.αλφα.-τριολ-3,20-διονης
AU649472B2 (en) New pregna-1,4-diene-3,20-dione-16-17-acetal-21 esters, process for their preparation, compositions and method for the treatment of inflammatory conditions
HK1005881B (en) Pregna-1,4-diene-3,20-dione-16-17-acetal-21 esters
DE10199030I1 (de) Substituierte Androsta-1, 4-dien-3, 17-dione und Verfahren zu deren Herstellung
ITMI942626A0 (it) Composti diastereomericamente puri derivati da 3-oxo e 3-tioxo-4-azaandrostani e loro uso come antiandrogeni
FI874189L (fi) Epimeerisen jakaantumisen säätelymenetelmä pregnaanijohdannaisten 16,17-asetaalien valmistuksessa
ATA100797A (de) Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung
ATE195937T1 (de) Pyridazinone-derivate und verfahren zur deren herstellung
DE19681535T1 (de) Kathodenelement und Verfahren für dessen Herstellung
HUT61570A (en) Process for producing pregna-1,4-diene-3,20-dione derivatives
ATE204268T1 (de) Diarylmethylidenefuran-derivate, verfahren zu deren herstellung und ihre verwendungen in therapie
IL126539A (en) Pregnane derivatives with no alpha-17 substituent, their medicinal use and manufacturing method
DE69626699T2 (de) Weichlothülse und verfahren zu deren herstellung
SI0929566T1 (en) Process for r-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11.beta.,16.alpha.,17.alpha.-triol-3,20-dione derivatives
LV5274A3 (lv) 22(R,S)-11 beta,21-dihidroksi-16 alpha,17-butilidenbisoksipregna-1,4-dien-3,20-diona iegusanas panemiens
HU9902346D0 (en) New pregna-1,4-diene-3,20-dione derivatives
ATA157794A (de) Isoliertes rohr sowie verfahren zu seiner herstellung
DE59610366D1 (de) Integrierte Einstellhilfe für Teleskopstützen und Verfahren zu deren Herstellung
AR243198A1 (es) Procedimiento para la elaboracion de compuesto 9alfa-21-dihalogeno-11beta- hidroxi-17alfa-alcanoiloxi-6alfa-fluor-16beta-metilp regna-1,4-dien-3,20-diona
LV11102A (lv) Virushepatita ar holestazes sindromu diagnostikas metode
HUT72588A (en) New 16-(substituted methyl)-pregna-1,4-diene-3,20-dione derivatives and process for producing them
DE69739130D1 (de) 5-alkoxy-2(3h)-oxazolonderivate und verfahren zu ihrer herstellung
DE69521417D1 (de) Kapillarrohr und verfahren zu dessen herstellung
HUP9904410A3 (en) Process for the purification of 11betha-21-dihydroxy-2'-methyl-5'betha-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione
ZA919813B (en) Use of 2beta,16beta-diamino-3alpha,17-dihydroxy androstane derivatives